Dang Research


Name: Hien Dang, PhD
Position: Assistant Professor

1025 Walnut Street
603 College Building
Philadelphia, PA 19107

Contact Number(s):

Our Team

Hien Dang, PhD
Principal Investigator

Dr. Dang earned her PhD in Molecular Medicine from Penn State University, followed by an outstanding Postdoctoral Fellowship at the National Cancer Institute (NCI). She began her own lab at Jefferson’s Department of Surgery in October 2018 focusing on oncogenic RNA binding proteins in hepatocellular carcinoma (HCC). 

Loves tacos and cannot lie.

Highlighted achievements include:

  • the discovery of a novel RNA binding protein (RBP) gene signature that predicts treatment response in liver cancer patients 
  • planning and development of national and international collaborations
  • execution of many large-scale studies 

Anna Barry, MS
Research Assistant II

Project: Using CRISPR/Cas9 to develop and validate models to study NELF-E in HCC. Also exploring AGO2 as a possible oncogenic RBP.

Loves going to the beach, hiking, & Founders craft beer.

Ryan Lamm, MD
General Surgery Resident
Thomas Jefferson University Hospital

Project: Genome-wide CRISPR/Cas9 screen to identify therapeutic targets against NELFE-driven HCCs.

Was once the lead singer in a rock band.

Adam Wojnar, MS
Research Assistant II

Project: Using bioinformatics to investigate the relationship between NELFE and MYC-induced HCCs.

Believes cheese and beef jerky are the two greatest things in the world.

Laura Reynolds 
Doctoral Candidate 

Project: Validating a therapeutic targeting NELFE in HCC and investigating the mechanisms of NELFE in liver cancer.

Loves photography and going for walks around the city.

Former Team Members

Rajkumar Baldeosingh, MS
Contractor, Sparks Therapeutics


Michelle Schafer, BSc 
Medical Student
Thomas Jefferson University


Kai Zhang, PhD
Assistant Professor
Nanjing University, China